CAR-T Therapy From IIT Bombay Recognized Among Top 3 National Innovations

IIT Bombay CAR-T Therapy | Nov 06, 2025

DBT, via the Biomanufacturing initiative under the BioE3 Policy, gave funding to IIT Bombay startup ImmunoAct.

IIT Bombay's ImmunoACT Receives Approval For India’s First CAR-T Cell Therapy

Health | Oct 13, 2023

Immunoadoptive Cell Therapy Private Limited (ImmunoACT) is an IIT Bombay incubated company founded in 2018, with the objective of tra..